IndraLab

Statements

USP22 activates sorafenib. 1 / 1

| 1

➶

reach

"The USP22 targeting lipopolyplexes caused high tumour inhibition and high sorafenib sensitivity in mice bearing HCC."

31776228

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

USP22 activates sorafenib. 1 / 1

INDRA sources:

Databases

Reading